<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:07:53Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6001798" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:6001798</identifier><datestamp>2018-06-21</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id>
      <journal-id journal-id-type="iso-abbrev">Hum. Mutat</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1098-1004</journal-id>
      <journal-id journal-id-type="publisher-id">HUMU</journal-id>
      <journal-title-group>
        <journal-title>Human Mutation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1059-7794</issn>
      <issn pub-type="epub">1098-1004</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC6001798</article-id>
      <article-id pub-id-type="pmcid">PMC6001798</article-id>
      <article-id pub-id-type="pmc-uid">6001798</article-id>
      <article-id pub-id-type="pmid">29573052</article-id>
      <article-id pub-id-type="doi">10.1002/humu.23420</article-id>
      <article-id pub-id-type="publisher-id">HUMU23420</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Brief Report</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Brief Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A homozygous variant disrupting the <italic>PIGH</italic> startâcodon is associated with developmental delay, epilepsy, and microcephaly</article-title>
        <alt-title alt-title-type="left-running-head">PAGNAMENTA etÂ al.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="humu23420-cr-0001" contrib-type="author" corresp="yes">
          <name>
            <surname>Pagnamenta</surname>
            <given-names>Alistair T.</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7334-0602</contrib-id>
          <address>
            <email>alistair@well.ox.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="humu23420-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="humu23420-note-0002">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0002" contrib-type="author">
          <name>
            <surname>Murakami</surname>
            <given-names>Yoshiko</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4870-5734</contrib-id>
          <xref ref-type="aff" rid="humu23420-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="humu23420-aff-0003">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="humu23420-note-0002">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0003" contrib-type="author">
          <name>
            <surname>Anzilotti</surname>
            <given-names>Consuelo</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0004" contrib-type="author">
          <name>
            <surname>Titheradge</surname>
            <given-names>Hannah</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0005" contrib-type="author">
          <name>
            <surname>Oates</surname>
            <given-names>Adam J.</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0006" contrib-type="author">
          <name>
            <surname>Morton</surname>
            <given-names>Jenny</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0007" contrib-type="author">
          <collab collab-type="authors">The DDD Study</collab>
          <xref ref-type="aff" rid="humu23420-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0008" contrib-type="author">
          <name>
            <surname>Kinoshita</surname>
            <given-names>Taroh</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="humu23420-aff-0003">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="humu23420-note-0002">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0009" contrib-type="author" corresp="yes">
          <name>
            <surname>Kini</surname>
            <given-names>Usha</given-names>
          </name>
          <address>
            <email>usha.kini@ouh.nhs.uk</email>
          </address>
          <xref ref-type="aff" rid="humu23420-aff-0008">
<sup>8</sup>
</xref>
          <xref ref-type="author-notes" rid="humu23420-note-0002">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="humu23420-cr-0010" contrib-type="author">
          <name>
            <surname>Taylor</surname>
            <given-names>Jenny C.</given-names>
          </name>
          <xref ref-type="aff" rid="humu23420-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="humu23420-note-0002">
<sup>â </sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="humu23420-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">National Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics</named-content>
<institution>University of Oxford</institution>
<named-content content-type="city">Oxford</named-content>
<named-content content-type="country-part">Oxfordshire</named-content>
<country country="GB">UK</country>
</aff>
      <aff id="humu23420-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Yabumoto Department of Intractable Disease Research, Research Institute for Microbial Diseases</named-content>
<institution>Osaka University</institution>
<named-content content-type="city">Osaka</named-content>
<country country="JP">Japan</country>
</aff>
      <aff id="humu23420-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">World Premier International Immunology Frontier Research Center</named-content>
<institution>Osaka University</institution>
<named-content content-type="city">Osaka</named-content>
<country country="JP">Japan</country>
</aff>
      <aff id="humu23420-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine</named-content>
<institution>John Radcliffe Hospital, University of Oxford</institution>
<named-content content-type="city">Oxford</named-content>
<country country="GB">UK</country>
</aff>
      <aff id="humu23420-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's NHS Foundation Trust</named-content>
<institution>Birmingham Women's Hospital, Mindelsohn Way</institution>
<named-content content-type="street">Edgbaston</named-content>
<named-content content-type="city">Birmingham</named-content>
<country country="GB">UK</country>
</aff>
      <aff id="humu23420-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">Radiology Department</named-content>
<institution>Birmingham Children's Hospital</institution>
<named-content content-type="city">Birmingham</named-content>
<country country="GB">UK</country>
</aff>
      <aff id="humu23420-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Wellcome Trust Sanger Institute</named-content>
<institution>Wellcome Genome Campus</institution>
<named-content content-type="street">Hinxton</named-content>
<named-content content-type="city">Cambridge</named-content>
<country country="GB">UK</country>
</aff>
      <aff id="humu23420-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Oxford Centre for Genomic Medicine</named-content>
<institution>Oxford University Hospitals NHS Foundation Trust</institution>
<named-content content-type="city">Oxford</named-content>
<country country="GB">UK</country>
</aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>Alistair Pagnamenta, Wellcome Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK.<break/>Email: <email>alistair@well.ox.ac.uk</email><break/>Usha Kini, Oxford Centre for Genomic Medicine, ACE building, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Windmill Road, Headington, Oxford OX3 7HE, UK.<break/>Email: <email>usha.kini@ouh.nhs.uk</email><break/></corresp>
        <fn id="humu23420-note-0002">
          <label>â </label>
          <p>Alistair T. Pagnamenta, Yoshiko Murakami, Taroh Kinoshita, Usha Kini, and Jenny C. Taylor contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>3</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2018</year>
      </pub-date>
      <volume>39</volume>
      <issue>6</issue>
      <issue-id pub-id-type="doi">10.1002/humu.2018.39.issue-6</issue-id>
      <fpage>822</fpage>
      <lpage>826</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>12</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>09</day>
          <month>2</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>3</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 Wiley Periodicals, Inc. <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2018 The Authors. <italic>Human Mutation</italic> published by Wiley Periodicals, Inc.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:HUMU-39-822.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Defective glycosylphosphatidylinositol (GPI)âanchor biogenesis can cause a spectrum of predominantly neurological problems. For eight genes critical to this biological process, disease associations are not yet reported. Scanning exomes from 7,833 parentâchild trios and 1,792 singletons from the DDD study for biallelic variants in this geneâset uncovered a rare <italic>PIGH</italic> variant in a boy with epilepsy, microcephaly, and behavioral difficulties. Although only 2/2 reads harbored this c.1AÂ &gt;Â T transversion, the presence of â¼25Â Mb autozygosity at this locus implied homozygosity, which was confirmed using Sanger sequencing. A similarlyâaffected sister was also homozygous. FACS analysis of <italic>PIGH</italic>âdeficient CHO cells indicated that cDNAs with c.1AÂ &gt;Â T could not efficiently restore expression of GPIâAPs. Truncation of PIGH protein was consistent with the utilization of an inâframe startâsite at codon 63. In summary, we describe siblings harboring a homozygous c.1AÂ &gt;Â T variant resulting in defective GPIâanchor biogenesis and highlight the importance of exploring lowâcoverage variants within autozygous regions.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="humu23420-kwd-0001">developmental delay</kwd>
        <kwd id="humu23420-kwd-0002">exome</kwd>
        <kwd id="humu23420-kwd-0003">GPIâanchor biogenesis</kwd>
        <kwd id="humu23420-kwd-0004">microcephaly</kwd>
        <kwd id="humu23420-kwd-0005">phosphatidylinositol Nâacetylglucosaminyltransferase</kwd>
        <kwd id="humu23420-kwd-0006">PIGH</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust</funding-source>
          <award-id>090532/Z/09/Z</award-id>
        </award-group>
        <award-group>
          <funding-source>National Institute for Health Research</funding-source>
        </award-group>
        <award-group>
          <funding-source>Japanese Agency for Medical Research and Development</funding-source>
        </award-group>
        <award-group>
          <funding-source>Ministry of Health Labour and Welfare</funding-source>
        </award-group>
        <award-group>
          <funding-source>Health Innovation Challenge Fund</funding-source>
          <award-id>HICFâ1009â003</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="0"/>
        <page-count count="5"/>
        <word-count count="4356"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>humu23420</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>June 2018</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.1.1 mode:remove_FC converted:14.06.2018</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="journal" id="humu23420-cit-0020">
<string-name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Anzilotti</surname>
<given-names>C</given-names>
</string-name>, etÂ al. <article-title>A homozygous variant disrupting the <italic>PIGH</italic> startâcodon is associated with developmental delay, epilepsy and microcephaly</article-title>. <source xml:lang="en">Human Mutation</source>. <year>2018</year>;<volume>39</volume>:<fpage>822</fpage>â<lpage>826</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.23420">https://doi.org/10.1002/humu.23420</ext-link>
<pub-id pub-id-type="pmid">29573052</pub-id></mixed-citation>
</p>
      <fn-group>
        <fn id="humu23420-note-0003">
          <p>Communicated by Garry R. Cutting</p>
        </fn>
        <fn id="humu23420-note-0004">
          <p>
<bold>Funding information</bold> Contract grant sponsors: Wellcome Trust (090532/Z/09/Z); National Institute for Health Research (NIHR); Japanese Agency for Medical Research and Development; Ministry of Health Labour and Welfare; Health Innovation Challenge Fund (HICFâ1009â003); Department of Health; Wellcome Trust Sanger Institute [WT098051].</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <p>Rare genetic variants that result in defective glycosylphosphatidylinositol (GPI)âanchor biogenesis have been linked to a phenotypic spectrum of conditions that include learning disability, epilepsy, microcephaly, mild dysmorphic features, and other congenital malformations (Johnstone etÂ al., <xref rid="humu23420-bib-0007" ref-type="ref">2017</xref>; Makrythanasis etÂ al., <xref rid="humu23420-bib-0010" ref-type="ref">2016</xref>; Ng &amp; Freeze, <xref rid="humu23420-bib-0012" ref-type="ref">2015</xref>). Although more than 20 genes have been implicated to date, analysis of exome data from 4,293 trios showed that disease causing variants in this pathway account for only around 0.15% of cases with developmental disorders (Pagnamenta etÂ al., <xref rid="humu23420-bib-0013" ref-type="ref">2017</xref>). In this study, we interrogated the October 3, 2016 data release from the Deciphering Developmental Disorders (DDD) study (<ext-link ext-link-type="uri" xlink:href="http://www.ddduk.org">http://www.ddduk.org</ext-link>) comprising exomes for 7,833 parentâchild trios and 1,792 singletons. We specifically searched for biallelic variants in the remaining eight genes critical to this pathway for which human disease associations are yet to be reported: <italic>PIGB, PIGF, PIGH, PIGK, PIGS, PIGU, PIGX</italic>, and <italic>MPPE1</italic>.</p>
    <p>Patients were recruited to the DDD study under UK Research Ethics Committee approval (10/H0305/83; Cambridge South REC, and GEN/284/12; Republic of Ireland REC). In brief, reads were mapped to hs37d5 and variants were called using a combination of GATK, SAMtools, and Dindel for SNV and indels, and inâhouse CoNVex for CNVs. Candidate de novo variants were called in trio data with DeNovoGear. More detailed methods have been described previously (Deciphering Developmental Disorders, <xref rid="humu23420-bib-0004" ref-type="ref">2017</xref>; Wright etÂ al., <xref rid="humu23420-bib-0018" ref-type="ref">2015</xref>).</p>
    <p>The only variant in the restricted set of eight GPIâanchor biogenesis genes that passed all filter thresholds (&lt;1% AF in all subpopulations from gnomAD) and fits with the presumed autosomalârecessive inheritance pattern was an apparently homozygous c.1AÂ &gt;Â T; p.(Met1Leu) transversion in <italic>PIGH</italic> (MIM# 600154; NM_004569.3; rs761543313). This variant was identified in a boy (DECIPHER ID 265247 but referred to hereafter as IVâ1) with short stature, epilepsy, developmental delay, and behavioral difficulties. No other likely pathogenic variants have been identified in this boy. The c.1AÂ &gt;Â T variant was present in the gnomAD database (<ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org">https://gnomad.broadinstitute.org</ext-link>) at an overall allele frequency of 0.002% (4/172732 or 4/25236 in the South Asian subgroup; all observations in the heterozygous state) but absent from the 1000 Genome Project (phase3v5b).</p>
    <p>Unfortunately, exome coverage was very low at the <italic>PIGH</italic> start codon (2Ã, 3Ã, and 5Ã in the proband, mother, and father, respectively). Decreasing coverage below 15Ã increases the chance of heterozygous variants incorrectly being called homozygous, with very few heterozygous genotypes being called at 2Ã (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">1</xref>). However, the fact that both parents were heterozygous carriers of c.1AÂ &gt;Â T made the homozygous call in IVâ1 plausible. Review of high confidence SNVs on chr14 indicated that the c.AÂ &gt;Â T variant lay within a â¼25Â Mb region of autozygosity between rs2275504 and rs10131300 (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">2</xref>). Together with the documented consanguinity (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>A), this provided further support that the variant was homozygous. Bidirectional Sanger sequencing, performed using an ABI 3730XL instrument, later confirmed homozygosity in IVâ1 and his similarly affected sister (IVâ2), while both parents were heterozygous (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>B). The variant was also detected in an RNA sample obtained from the mother, suggesting that the mutant transcript is not significantly degraded (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">3</xref>). In silico analysis shows the variant has a PHREDâscaled CADD score of 27.6 and PolyPhenâ2 ranks it as possibly damaging.</p>
    <fig fig-type="Figure" xml:lang="en" id="humu23420-fig-0001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Pedigree, Sanger sequence data, and clinical images. <bold>A</bold>: Simplified pedigree for patient 265247, which shows parents to be firstâcousins. <bold>B</bold>: Genomic DNA was PCR amplified using FastStart Taq polymerase (Roche), with GCârich additive and primers CAGAGGGTGAAGAGTCCGTA and GGAAGAACGCACAACCATCA. Sanger sequencing of exoSAP purified PCR products, performed using BigDye v3.1 chemistry, confirmed that the c.1AÂ &gt;Â T variant was homozygous in both the proband and his affected sister (red arrows), while their parents were heterozygous carriers. The sequences shown are from the +ve strand primer but inverted to show the coding direction alongside the corresponding wildâtype amino acid sequence. The canonical methionine start codon is highlighted in green. <bold>C</bold>: Photograph of proband's hands demonstrating clinodactyly. <bold>D</bold>: Saggital T1 weighted MRI image of IVâ1 at 8Â years of age demonstrating a dysplastic corpus callosum with a slightly truncated and rounded appearance of the rostrum of the corpus callosum. Axial T2 FLAIR image demonstrating abnormal signal within the globus pallidi bilaterally but more prominent on the right. <bold>E</bold>: T1 weighted MRI scan for IVâ2 showing a very slightly dysplastic corpus callosum, again with a truncated appearance of the rostrum. <bold>F</bold>: Axial T2 weighted MRI scan images for IVâ2 showing nonspecific increased high signal foci in the deep white matter bilaterally, most notably in the parietal regions</p>
      </caption>
      <graphic id="nlm-graphic-3" xlink:href="HUMU-39-822-g001"/>
    </fig>
    <p>The proband (IVâ1) was born at 40Â weeks weighing 3.12Â kg (18th centile) to consanguineous Pakistani parents, following an uncomplicated pregnancy. His early development was reported to be normal; he walked at 14â15Â months and had said his first words by 1Â year of age. He developed febrile convulsions aged 14Â months, which progressed to afebrile generalized myoclonic seizures at 3Â years of age. These responded well to sodium valproate treatment. This treatment was stopped at the age of 12Â years and he has remained seizure free until 18Â years of age when he had one further seizure. Sodium valproate was subsequently recommenced. He had an episode of osteomyelitis of the left calcaneum at 6Â years of age. He has chronic otitis media with effusion. He has mild learning difficulties and attended mainstream school with support. He also had behavioral difficulties, and as a child, he was described as being overfriendly and tactile with strangers. As a teenager, he struggled to make friends and could be aggressive.</p>
    <p>On examination as a toddler, his height was on the 50th centile and weight over the 90th centile. At 9Â years of age, his occipitofrontal circumference (OFC) was between the 0.4 and 2nd centiles. His growth rate decelerated during childhood, and by the age of 12Â years 9Â months, his height was 141.4Â cm (7th centile), weight was 32Â kg (6th centile), and OFC was 51.1Â cm (1st centile). Clinodactyly of the 5th fingers (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>C) and toes was noted. Neither parent has clinodactyly. He had forward turned ear lobes and creases on the posterior aspect of the helices. He had dry skin, which has been suspected to represent ichthyosis. He also has a speckled lentiginous nevus on the right side of his torso. A diagnosis of SmithâMagenis syndrome was considered, but FISH for 17p11.2 was negative. Chromosome microarray analysis and <italic>SCN1A</italic> sequencing were normal. An MRI brain scan demonstrated subtle, nonâspecific findings including small areas of abnormal signal in both globus palladi (right more than left) and a dysplastic rostrum of the corpus callosum (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>D).</p>
    <p>His younger sister (IVâ2) was born after a normal pregnancy at 40Â weeks by normal vaginal delivery. She developed epilepsy with generalized tonic clonic seizures starting at 3.5Â years of age, initially febrile and then afebrile. The seizures have proved difficult to control and surgical treatment has been discussed. Similar to her brother, her initial development was normal. She also initially attended mainstream school with extra help, but was later moved to a special school. She has difficulties with both verbal and nonverbal communication. She also has behavioral difficulties with temper tantrums and aggressive behavior toward strangers. Skin pigmentation is normal. She has 5th toe clindactyly, but no other dysmorphic features, pigmentary or skin abnormalities. Her growth parameters at the age of 7.5Â years were: weight of 19.7Â kg (2â9th centile), height of 121Â cm (25â50th centile). OFC was 50.1Â cm, putting her between the 0.4 and 2nd centiles, whereas 2 years previously her OFC had been between the 25 and 50th centiles. Similar to her brother, her MRI brain scan has shown a mildly dysplastic corpus callosum (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>E) and nonâspecific foci of abnormal high signal in the deep white matter (FigureÂ <xref rid="humu23420-fig-0001" ref-type="fig">1</xref>F). A recent PET scan has shown increased uptake of glucose in the temporal regions. Neither parent has had similar symptoms or signs.</p>
    <p>Abnormal levels of alkaline phosphatase in blood serum are a biomarker for some forms of GPIâanchor deficiency, particularly when mutations involve <italic>PIGV, PIGO</italic>, <italic>PGAP2</italic>, or <italic>PGAP3</italic> (HPMRS1â4). However, in this case, alkaline phosphatase was within the normal range for both siblings; most recent measurements were 107Â IU/L (normal range 40â240) for IVâ1 and 228Â IU/L (84â307) for IVâ2. Triglyceride levels were in the normal range for IVâ1 (1.20Â mM) but significantly raised in IVâ2 (3.20Â mM; normal range 0.45â1.62). Raised triglyceride levels have been associated with patients with PIGA deficiency and it is speculated that this is due to a secondary deficiency of GPIHBP1 (TarailoâGraovac etÂ al., <xref rid="humu23420-bib-0017" ref-type="ref">2015</xref>).</p>
    <p>One method commonly used to functionally assess variants in genes associated with the GPIâanchor biogenesis is to perform FACS analysis on patient granulocytes. CD16 is often used as it is thought to be the most sensitive marker (Kato etÂ al., <xref rid="humu23420-bib-0008" ref-type="ref">2014</xref>; Tanigawa etÂ al., <xref rid="humu23420-bib-0016" ref-type="ref">2017</xref>). However, CD16 levels are also affected by how blood samples are handled and so patient samples are often compared to a small number of unrelated controls processed in the same batch. Such studies can potentially be confounded by the fact that granulocyte CD16 levels are variable among healthy individuals. In this study, FACS analysis demonstrated that IVâ1, IVâ2, and IIIâ2 all had median CD16 levels in between with the values obtained for two unrelated control subjects (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">4</xref>). To minimize the effects of genetic background and/or environmental factors, the functional consequences of the c.1AÂ &gt;Â T variant was assessed using plasmids containing wildâtype or mutant <italic>PIGH</italic> cDNA, which were transfected by electroporation (400Â Î¼l, 250Â V, 950Â Î¼F, Gene Pulser II; BioâRad, Tokyo, Japan) into <italic>PIGH</italic>âdeficient CHO cells. Coâtransfection with a luciferaseâexpressing plasmid was used to monitor transfection efficiency. Two days after transfection, restoration of GPIâAP was analyzed by FACS. Although no difference was observed when using a strong SR alpha promoter (pME), when expression was driven by a weaker TK promoter (pTK), mutant <italic>PIGH</italic> could not efficiently restore the surface expression of GPIâAPs (FigureÂ <xref rid="humu23420-fig-0002" ref-type="fig">2</xref>A). Western blot analysis of protein expression using the pME construct demonstrated that the variant results in a truncated version of PIGH, consistent with utilization of an alternate inâframe start site in exon 2 at the next available methionine codon at position 63 (FigureÂ <xref rid="humu23420-fig-0002" ref-type="fig">2</xref>B).</p>
    <fig fig-type="Figure" xml:lang="en" id="humu23420-fig-0002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>FACS and Western blot analysis using CHO cells. <bold>A</bold>: <italic>PIGHâ</italic>knockout CHO cells were generated and transfected with human wildâtype or c.1AÂ &gt;Â T mutant <italic>PIGH</italic> cDNA cloned into pME or pTK expression vectors. Restoration of the cell surface expression of CD59, DAF, and uPAR was evaluated by flow cytometry. AntiâCD59 (5H8), DAF (IA10), and uPAR (5D6) were made in house. The mutant construct using the pTK promoter did not rescue surface expression of CD59 or uPAR as efficiently as the wildâtype construct, indicating that the variant results in reduced PIGH activity. <bold>B</bold>: Levels of expressed wildâtype and c.1AÂ &gt;Â T mutant HAâtagged PIGH in pMEâvector transfected cells were analyzed by Western blotting using an antiâHA antibody (C29F4 Rabbit mAb; Cell Signaling; 1:15,000). After normalization with luciferase activity and GAPDH (AntiâGAPDH, AM4300 mouse mAb Ambion; 1:2,000), expression of fullâlength PIGH (*) was reduced almost to zero and instead there was a smaller band (**), which likely represents a truncated version of PIGH in which translation starts from an alternative Met63 codon in exon 2. Although a larger band can be detected at around 30Â kDa (***), it is unclear where this starts because there are no inâframe methionine codons upstream</p>
      </caption>
      <graphic id="nlm-graphic-5" xlink:href="HUMU-39-822-g002"/>
    </fig>
    <p>
<italic>PIGH</italic> encodes a relatively small endoplasmic reticulumâassociated protein of 188 amino acids. Together with five other subunits, PIGH is an essential component of phosphatidylinositol (PI) Nâacetylglucosaminyltransferase, an enzyme that is critical for the first step in GPIâanchor biosynthesis. The enzyme catalyzes the transfer of Nâacetylglucosamine (GlcNAc) from uridine 5â²âdiphospho Nâacetyl glucosamine (UDPâGlcNAc) to PI to form GlcNacâPI (EC 2.4.1.198). Studies on the orthologous gene in yeast suggest the PIGH subunit is critical for biological activity (Yan, Westfall, &amp; Orlean, <xref rid="humu23420-bib-0019" ref-type="ref">2001</xref>). Although truncation of amino acids 1â62 (the likely effect of the c.1AÂ &gt;Â T variant) represents a loss of 33% of the wildâtype PIGH protein, our results suggest that some residual activity is retained (FigureÂ <xref rid="humu23420-fig-0002" ref-type="fig">2</xref>A). However, studies have shown that in certain situations, initiation from UUG codons can occur (Kearse &amp; Wilusz, <xref rid="humu23420-bib-0009" ref-type="ref">2017</xref>) and so it is also possible a trace amount of fullâsize PIGH, likely generated using Leu1 (FigureÂ <xref rid="humu23420-fig-0002" ref-type="fig">2</xref>B), contributed to the residual activity.</p>
    <p>Although a <italic>PIGH</italic> splicing variant in Belgian Blue cattle has been shown to result in arthrogryposis (Sartelet etÂ al., <xref rid="humu23420-bib-0014" ref-type="ref">2015</xref>), the consequences of <italic>PIGH</italic> mutations in humans have not yet been described. In contrast, phenotypes associated with germline variants in the five genes encoding the other essential components of this complex have already been elucidated. Germline mutations in <italic>PIGA</italic> were originally reported to cause a Xâlinked lethal disorder involving cleft palate, neonatal seizures, contractures, central nervous system structural malformations, and other anomalies (Johnston etÂ al., <xref rid="humu23420-bib-0021" ref-type="ref">2012</xref>). Milder cases have since been described where the manifestation include profound learning disability, axial hypotonia, epilepsy, and hypsarrhythmia (Belet etÂ al., <xref rid="humu23420-bib-0002" ref-type="ref">2014</xref>) or neurodegenerative encephalopathy with systemic iron overload and ichthyosiform skin lesions (Swoboda etÂ al., <xref rid="humu23420-bib-0015" ref-type="ref">2014</xref>). A homozygous splice variant in <italic>PIGQ</italic> has been linked to Ohtahara syndrome (Martin etÂ al., <xref rid="humu23420-bib-0011" ref-type="ref">2014</xref>) whilst a p.(R207*) alteration has been linked to intractable seizures, developmental delay, and optic atrophy (Alazami etÂ al., <xref rid="humu23420-bib-0001" ref-type="ref">2015</xref>). A missense variant in <italic>PIGY</italic> resulted in a multiâsystem disease involving dysmorphism, epilepsy, severe developmental delay, cataracts, and early death, while a regulatory variant was associated with a milder presentation limited to moderate development delay and microcephaly (Ilkovski etÂ al., <xref rid="humu23420-bib-0006" ref-type="ref">2015</xref>). Mutations in <italic>PIGC</italic> are associated with epilepsy and intellectual disability (Edvardson etÂ al., <xref rid="humu23420-bib-0005" ref-type="ref">2017</xref>), while those in <italic>PIGP</italic> have been linked to infantile epileptic encephalopathy (Johnstone etÂ al., <xref rid="humu23420-bib-0007" ref-type="ref">2017</xref>). To sum up, although epilepsy is a common finding, many other variable features can coâoccur. We speculate that the relatively mild phenotype observed in the siblings described here is due to some residual activity and that biallelic <italic>PIGH</italic> mutations that result in zero activity would lead to a significantly more severe presentation. Further studies and the recruitment of additional patients with <italic>PIGH</italic> variants would be required to test this hypothesis.</p>
    <p>GC content is well known to influence the resulting read coverage obtained by exome capture methodologies (Clark etÂ al., <xref rid="humu23420-bib-0003" ref-type="ref">2011</xref>). Due to the presence of CpG islands at the 5â² ends of many genes, genetic variants in or around the startâcodon are therefore less likely to be called robustly than in other gene regions (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">5</xref>). In this case, we identified a homozygous c.1AÂ &gt;Â T with only 2Ã coverage. In a previous study, we identified a homozygous c.â540GÂ &gt;Â A variant in the <italic>PIGY</italic> promoter, with only 4Ã coverage (Ilkovski etÂ al., <xref rid="humu23420-bib-0006" ref-type="ref">2015</xref>). Variants with these levels of coverage are often considered lowâconfidence and filtered out at early stages of analysis. Even if retained, low coverage variants are less likely to be genotyped accurately in terms of distinguishing heterozygosity from homozygosity (Supp. FigureÂ <xref rid="humu23420-supl-0001" ref-type="supplementary-material">1</xref>). Together, these studies highlight the value of scrutinizing low coverage variants involving transcriptional or translational start sites, especially when they lie within regions of autozygosity. Our systematic analysis identified two siblings from the DDD study with homozygous disruption of the <italic>PIGH</italic> start codon, which leads to the use of an alternative start site and defective GPIâanchor biogenesis resulting in a developmental disorder characterized by developmental delay, seizures, and microcephaly. Further cases are required to confirm the phenotypic range associated with rare biallelic <italic>PIGH</italic> variants.</p>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data" id="humu23420-supl-0001">
        <caption>
          <p>
<bold>Figure S1</bold>. Percentage of variants detected at difference levels of coverage that are called homozygous in individual IVâ1. The numbers of variants called that fit into each coverage bin are indicated. Analysis was restricted to variants present in known databases such as dbSNP or COSMIC. Variants on the X and Y chromosomes were not included. Decreasing coverage increases the likelihood of a variant being called homozygous. Very few heterozygous genotypes are able to be called at 2x coverage, the level of coverage obtained at the site of the c.1AÂ &gt;Â T variant in <italic>PIGH</italic>.</p>
          <p>
<bold>Figure S2</bold>. Bâallele frequency plot for 2657 high confidence variants detected along chromosome 14. Only SNVs with a PASS flag and coverage of 15x or more are shown. <italic>PIGH</italic> (NM_004569.3) is situated at chr14:68,056,023â68,067,017 and so appears to lie within a â¼25Â Mb region of autozygosity between chr14:47,770,841â72,939,495.</p>
          <p>
<bold>Figure S3</bold>. RNA analysis for individual IIIâ2. Blood was collected from the mother and two control subjects using PAXgene blood RNA tubes (Qiagen). RNA was extracted using the PAXgene Blood RNA Kit (Qiagen) and reverseâtranscribed using the QuantiTect RT kit (Qiagen). PCR amplification was performed using AGGTAGTGCTTTCTTTGCCTGA and CGAGACGACCAGGGCCGG primers where underlined base corresponds to the nonâreference base at rs7154825 which is the major allele. A) Gel image showing a PCR product of the expected size (403Â bp) was obtained and no bands were observed in the RT negative control lanes. B) Sanger sequencing of PCR products was done using BigDye v3.1 chemistry on an ABI 3730XL instrument. For ease of comparison, the electropherograms are shown below the trace obtained using the mother's genomic DNA. The peaks corresponding to the wildâtype and c.1AÂ &gt;Â T alleles are of similar height, matching what is seen for genomic DNA. This suggests that the mutant RNA is not degraded significantly.</p>
          <p>
<bold>Figure S4</bold>. FACS analysis of CD16 expression in granulocytes from three family members and two healthy donor controls. Heparinized blood samples were treated with ACK lysis buffer and stained with a 1:100 dilution of antiâhuman CD16 (3G8, Invitrogen). Samples were run on a BD FACSCanto and data analysed by FlowJo. Granulocytes were identified according to FSc and SSc profile. Median expression levels of CD16 for all three family members were in between two control subjects. All samples were collected at the same time and processed in the same way the following day.</p>
          <p>
<bold>Figure S5</bold>. Median number of noâcalled samples in ExAC release 0.3.1 for AÂ &gt;Â T variants spaced at regular 100Â bp intervals along all genes combined. Annotations were based on Gencode version 19 and using VEP version 85 as described at http://exac.broadinstitute.org. Values were taken for the âNCCâ information field for all autosomal SNVs. Indels and variants where there were multiple nonâreference alleles were excluded.</p>
        </caption>
        <media xlink:href="HUMU-39-822-s001.pdf">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="humu23420-sec-0020">
      <title>ACKNOWLEDGMENTS</title>
      <p>We thank the family who kindly agreed to participate in this study and the Genome Aggregation Database (<ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org">https://gnomad.broadinstitute.org</ext-link>) and the groups that provided exome and genome variant data to this resource. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, the Wellcome Trust or the Department of Health.</p>
    </ack>
    <ack id="humu23420-sec-0030">
      <title>DISCLOSURE STATEMENT</title>
      <p>The authors declare no conflict of interest.</p>
    </ack>
    <ref-list id="humu23420-bibl-0001">
      <title>REFERENCES</title>
      <ref id="humu23420-bib-0001">
        <mixed-citation publication-type="journal" id="humu23420-cit-0001">
<string-name>
<surname>Alazami</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Patel</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Shamseldin</surname>, <given-names>H. E.</given-names>
</string-name>, <string-name>
<surname>Anazi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>AlâDosari</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Alzahrani</surname>, <given-names>F.</given-names>
</string-name>, â¦ <string-name>
<surname>Alkuraya</surname>, <given-names>F. S.</given-names>
</string-name> (<year>2015</year>). <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via wholeâexome sequencing of prescreened multiplex consanguineous families</article-title>. <source xml:lang="en">Cell Reports</source>, <volume>10</volume>(<issue>2</issue>), <fpage>148</fpage>â<lpage>161</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2014.12.015">https://doi.org/10.1016/j.celrep.2014.12.015</ext-link>
<pub-id pub-id-type="pmid">25558065</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0002">
        <mixed-citation publication-type="journal" id="humu23420-cit-0002">
<string-name>
<surname>Belet</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Fieremans</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Van Esch</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Verbeeck</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Ye</surname>, <given-names>Z.</given-names>
</string-name>, â¦ <string-name>
<surname>Froyen</surname>, <given-names>G.</given-names>
</string-name> (<year>2014</year>). <article-title>Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>35</volume>(<issue>3</issue>), <fpage>350</fpage>â<lpage>355</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.22498">https://doi.org/10.1002/humu.22498</ext-link>
<pub-id pub-id-type="pmid">24357517</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0003">
        <mixed-citation publication-type="journal" id="humu23420-cit-0003">
<string-name>
<surname>Clark</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lam</surname>, <given-names>H. Y.</given-names>
</string-name>, <string-name>
<surname>Karczewski</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Euskirchen</surname>, <given-names>G.</given-names>
</string-name>, â¦ <string-name>
<surname>Snyder</surname>, <given-names>M.</given-names>
</string-name> (<year>2011</year>). <article-title>Performance comparison of exome DNA sequencing technologies</article-title>. <source xml:lang="en">Nature Biotechnology</source>, <volume>29</volume>(<issue>10</issue>), <fpage>908</fpage>â<lpage>914</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nbt.1975">https://doi.org/10.1038/nbt.1975</ext-link>
</mixed-citation>
      </ref>
      <ref id="humu23420-bib-0004">
        <mixed-citation publication-type="journal" id="humu23420-cit-0004">
<collab collab-type="authors">Deciphering Developmental Disorders Study</collab>
. (<year>2017</year>). <article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>. <source xml:lang="en">Nature</source>, <volume>542</volume>(<issue>7642</issue>), <fpage>433</fpage>â<lpage>438</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature21062">https://doi.org/10.1038/nature21062</ext-link>
<pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0005">
        <mixed-citation publication-type="journal" id="humu23420-cit-0005">
<string-name>
<surname>Edvardson</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>T. T.</given-names>
</string-name>, <string-name>
<surname>Shahrour</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>StâDenis</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Shaag</surname>, <given-names>A.</given-names>
</string-name>, â¦ <string-name>
<surname>Elpeleg</surname>, <given-names>O.</given-names>
</string-name> (<year>2017</year>). <article-title>Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability</article-title>. <source xml:lang="en">Journal of Medical Genetics</source>, <volume>54</volume>(<issue>3</issue>), <fpage>196</fpage>â<lpage>201</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jmedgenet-2016-104202">https://doi.org/10.1136/jmedgenet-2016-104202</ext-link>
<pub-id pub-id-type="pmid">27694521</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0006">
        <mixed-citation publication-type="journal" id="humu23420-cit-0006">
<string-name>
<surname>Ilkovski</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Pagnamenta</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>O'Grady</surname>, <given-names>G. L.</given-names>
</string-name>, <string-name>
<surname>Kinoshita</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Howard</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Lek</surname>, <given-names>M.</given-names>
</string-name>, â¦ <string-name>
<surname>Clarke</surname>, <given-names>N. F.</given-names>
</string-name> (<year>2015</year>). <article-title>Mutations in PIGY: Expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies</article-title>. <source xml:lang="en">Human Molecular Genetics</source>, <volume>24</volume>(<issue>21</issue>), <fpage>6146</fpage>â<lpage>6159</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddv331">https://doi.org/10.1093/hmg/ddv331</ext-link>
<pub-id pub-id-type="pmid">26293662</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0021">
        <mixed-citation publication-type="journal" id="humu23420-cit-0021">
<string-name>
<surname>Johnston</surname>, <given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Gropman</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Sapp</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Teer</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>C. F.</given-names>
</string-name>, â¦ <string-name>
<surname>Biesecker</surname>, <given-names>L. G.</given-names>
</string-name> (<year>2012</year>). <article-title>The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria</article-title>. <source xml:lang="en">American Journal of Human Genetics</source>, <volume>90</volume>(<issue>2</issue>), <fpage>295</fpage>â<lpage>300</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2011.11.031">https://doi.org/10.1016/j.ajhg.2011.11.031</ext-link>
<pub-id pub-id-type="pmid">22305531</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0007">
        <mixed-citation publication-type="journal" id="humu23420-cit-0007">
<string-name>
<surname>Johnstone</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Nguyen</surname>, <given-names>T. T.</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kernohan</surname>, <given-names>K. D.</given-names>
</string-name>, <string-name>
<surname>Tetreault</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Goldsmith</surname>, <given-names>C.</given-names>
</string-name>, â¦ <string-name>
<surname>Campeau</surname>, <given-names>P. M.</given-names>
</string-name> (<year>2017</year>). <article-title>Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy</article-title>. <source xml:lang="en">Human Molecular Genetics</source>, <volume>26</volume>(<issue>9</issue>), <fpage>1706</fpage>â<lpage>1715</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddx077">https://doi.org/10.1093/hmg/ddx077</ext-link>
<pub-id pub-id-type="pmid">28334793</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0008">
        <mixed-citation publication-type="journal" id="humu23420-cit-0008">
<string-name>
<surname>Kato</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Saitsu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Iai</surname>, <given-names>M.</given-names>
</string-name>, â¦ <string-name>
<surname>Matsumoto</surname>, <given-names>N.</given-names>
</string-name> (<year>2014</year>). <article-title>PIGA mutations cause earlyâonset epileptic encephalopathies and distinctive features</article-title>. <source xml:lang="en">Neurology</source>, <volume>82</volume>(<issue>18</issue>), <fpage>1587</fpage>â<lpage>1596</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0000000000000389">https://doi.org/10.1212/WNL.0000000000000389</ext-link>
<pub-id pub-id-type="pmid">24706016</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0009">
        <mixed-citation publication-type="journal" id="humu23420-cit-0009">
<string-name>
<surname>Kearse</surname>, <given-names>M. G.</given-names>
</string-name>, &amp; <string-name>
<surname>Wilusz</surname>, <given-names>J. E.</given-names>
</string-name> (<year>2017</year>). <article-title>NonâAUG translation: A new start for protein synthesis in eukaryotes</article-title>. <source xml:lang="en">Genes Development</source>, <volume>31</volume>(<issue>17</issue>), <fpage>1717</fpage>â<lpage>1731</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/gad.305250.117">https://doi.org/10.1101/gad.305250.117</ext-link>
<pub-id pub-id-type="pmid">28982758</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0010">
        <mixed-citation publication-type="journal" id="humu23420-cit-0010">
<string-name>
<surname>Makrythanasis</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Kato</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zaki</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Saitsu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Santoni</surname>, <given-names>F. A.</given-names>
</string-name>, â¦ <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name> (<year>2016</year>). <article-title>Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia</article-title>. <source xml:lang="en">American Journal of Human Genetics</source>, <volume>98</volume>(<issue>4</issue>), <fpage>615</fpage>â<lpage>626</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2016.02.007">https://doi.org/10.1016/j.ajhg.2016.02.007</ext-link>
<pub-id pub-id-type="pmid">26996948</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0011">
        <mixed-citation publication-type="journal" id="humu23420-cit-0011">
<string-name>
<surname>Martin</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>G. E.</given-names>
</string-name>, <string-name>
<surname>Pagnamenta</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Carvill</surname>, <given-names>G. L.</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>, <given-names>E.</given-names>
</string-name>, â¦ <string-name>
<surname>Taylor</surname>, <given-names>J. C.</given-names>
</string-name> (<year>2014</year>). <article-title>Clinical wholeâgenome sequencing in severe earlyâonset epilepsy reveals new genes and improves molecular diagnosis</article-title>. <source xml:lang="en">Human Molecular Genetics</source>, <volume>23</volume>(<issue>12</issue>), <fpage>3200</fpage>â<lpage>3211</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/hmg/ddu030">https://doi.org/10.1093/hmg/ddu030</ext-link>
<pub-id pub-id-type="pmid">24463883</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0012">
        <mixed-citation publication-type="journal" id="humu23420-cit-0012">
<string-name>
<surname>Ng</surname>, <given-names>B. G.</given-names>
</string-name>, &amp; <string-name>
<surname>Freeze</surname>, <given-names>H. H.</given-names>
</string-name> (<year>2015</year>). <article-title>Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL)</article-title>. <source xml:lang="en">Journal of Inherited Metabolic Disease</source>, <volume>38</volume>(<issue>1</issue>), <fpage>171</fpage>â<lpage>178</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10545-014-9752-1">https://doi.org/10.1007/s10545-014-9752-1</ext-link>
<pub-id pub-id-type="pmid">25164783</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0013">
        <mixed-citation publication-type="journal" id="humu23420-cit-0013">
<string-name>
<surname>Pagnamenta</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Anzilotti</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Howard</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Miller</surname>, <given-names>V.</given-names>
</string-name>, â¦ <string-name>
<surname>Kini</surname>, <given-names>U.</given-names>
</string-name> (<year>2017</year>). <article-title>Analysis of exome data for 4293 trios suggests GPIâanchor biogenesis defects are a rare cause of developmental disorders</article-title>. <source xml:lang="en">European Journal of Human Genetics</source>, <volume>25</volume>(<issue>6</issue>), <fpage>669</fpage>â<lpage>679</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ejhg.2017.32">https://doi.org/10.1038/ejhg.2017.32</ext-link>
<pub-id pub-id-type="pmid">28327575</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0014">
        <mixed-citation publication-type="journal" id="humu23420-cit-0014">
<string-name>
<surname>Sartelet</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Pailhoux</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Richard</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Tamma</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Karim</surname>, <given-names>L.</given-names>
</string-name>, â¦ <string-name>
<surname>Charlier</surname>, <given-names>C.</given-names>
</string-name> (<year>2015</year>). <article-title>Genomeâwide nextâgeneration DNA and RNA sequencing reveals a mutation that perturbs splicing of the phosphatidylinositol glycan anchor biosynthesis class H gene (PIGH) and causes arthrogryposis in Belgian Blue cattle</article-title>. <source xml:lang="en">BMC Genomics</source>, <volume>16</volume>, <fpage>316</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12864-015-1528-y">https://doi.org/10.1186/s12864-015-1528-y</ext-link>
<pub-id pub-id-type="pmid">25895751</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0015">
        <mixed-citation publication-type="journal" id="humu23420-cit-0015">
<string-name>
<surname>Swoboda</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Margraf</surname>, <given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Carey</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Newcomb</surname>, <given-names>T. M.</given-names>
</string-name>, <string-name>
<surname>Coonrod</surname>, <given-names>E.</given-names>
</string-name>, â¦ <string-name>
<surname>Opitz</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2014</year>). <article-title>A novel germline PIGA mutation in FerroâCerebroâCutaneous syndrome: A neurodegenerative Xâlinked epileptic encephalopathy with systemic ironâoverload</article-title>. <source xml:lang="en">American Journal of Medical Genetics A</source>, <volume>164A</volume>(<issue>1</issue>), <fpage>17</fpage>â<lpage>28</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.a.36189">https://doi.org/10.1002/ajmg.a.36189</ext-link>
</mixed-citation>
      </ref>
      <ref id="humu23420-bib-0016">
        <mixed-citation publication-type="journal" id="humu23420-cit-0016">
<string-name>
<surname>Tanigawa</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Mimatsu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Mizuno</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Okamoto</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Fukushi</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Tominaga</surname>, <given-names>K.</given-names>
</string-name>, â¦ <string-name>
<surname>Murakami</surname>, <given-names>Y.</given-names>
</string-name> (<year>2017</year>). <article-title>Phenotypeâgenotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties</article-title>. <source xml:lang="en">Human Mutation</source>, <volume>38</volume>(<issue>7</issue>), <fpage>805</fpage>â<lpage>815</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.23219">https://doi.org/10.1002/humu.23219</ext-link>
<pub-id pub-id-type="pmid">28337824</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0017">
        <mixed-citation publication-type="journal" id="humu23420-cit-0017">
<string-name>
<surname>TarailoâGraovac</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sinclair</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>StocklerâIpsiroglu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Van Allen</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rozmus</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Shyr</surname>, <given-names>C.</given-names>
</string-name>, â¦ <string-name>
<surname>van Karnebeek</surname>, <given-names>C. D.</given-names>
</string-name> (<year>2015</year>). <article-title>The genotypic and phenotypic spectrum of PIGA deficiency</article-title>. <source xml:lang="en">Orphanet Journal of Rare Diseases</source>, <volume>10</volume>, <fpage>23</fpage>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13023-015-0243-8">https://doi.org/10.1186/s13023-015-0243-8</ext-link>
<pub-id pub-id-type="pmid">25885527</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0018">
        <mixed-citation publication-type="journal" id="humu23420-cit-0018">
<string-name>
<surname>Wright</surname>, <given-names>C. F.</given-names>
</string-name>, <string-name>
<surname>Fitzgerald</surname>, <given-names>T. W.</given-names>
</string-name>, <string-name>
<surname>Jones</surname>, <given-names>W. D.</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>McRae</surname>, <given-names>J. F.</given-names>
</string-name>, <string-name>
<surname>van Kogelenberg</surname>, <given-names>M.</given-names>
</string-name> â¦ <collab collab-type="authors">DDD Study</collab>
. (<year>2015</year>). <article-title>Genetic diagnosis of developmental disorders in the DDD study: A scalable analysis of genomeâwide research data</article-title>. <source xml:lang="en">Lancet</source>, <volume>385</volume>(<issue>9975</issue>), <fpage>1305</fpage>â<lpage>1314</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(14)61705-0">https://doi.org/10.1016/S0140-6736(14)61705-0</ext-link>
<pub-id pub-id-type="pmid">25529582</pub-id></mixed-citation>
      </ref>
      <ref id="humu23420-bib-0019">
        <mixed-citation publication-type="journal" id="humu23420-cit-0019">
<string-name>
<surname>Yan</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Westfall</surname>, <given-names>B. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Orlean</surname>, <given-names>P.</given-names>
</string-name> (<year>2001</year>). <article-title>Ynl038wp (Gpi15p) is the Saccharomyces cerevisiae homologue of human PigâHp and participates in the first step in glycosylphosphatidylinositol assembly</article-title>. <source xml:lang="en">Yeast</source>, <volume>18</volume>(<issue>15</issue>), <fpage>1383</fpage>â<lpage>1389</lpage>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/yea.783">https://doi.org/10.1002/yea.783</ext-link>
<pub-id pub-id-type="pmid">11746600</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>